New combo therapy extends life for advanced bile duct cancer patients
NCT ID NCT05024513
First seen Jan 04, 2026 · Last updated Jun 10, 2026 · Updated 26 times
Summary
This study looked at people with advanced bile duct cancer that cannot be removed by surgery. It compared standard bile duct drainage alone to drainage plus a targeted chemotherapy given directly into the liver artery. The goal was to see if adding this chemo could help patients live longer and control the tumor better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIHILAR CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Interventional Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education),Peking University Cancer Hospital and Institute
Beijing, China
Conditions
Explore the condition pages connected to this study.